CTMX
#2705
CytomX Therapeutics, Inc. - Common Stock
3.2 1 USD
-0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-6.14%
Monthly Change
+0.94%
6 month change
-38.15%
Year Change
+58.91%
Previous Close
3.4 2
Open
3.2 1
Low
3.2 1
High
3.2 1
Volume
82
Financials
- Market Capitalization 699.46 M
- Employee 69
- Founded 2008
- CEO N/A
- Website www.cytomx.com
- Headquarter Delaware, United States
- FIGI BBG001J472L3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.83
Price to sales ratio
7.71
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2697 |  STTK Shattuck Labs, Inc. - Common Stock | 7.04 USD | -7.97% | -8.09% | +2.77% | +611.11% | 706.56 M USD | ||
| 2703 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.74 USD | -4.79% | -0.91% | +5.68% | -3.10% | 700.72 M USD | ||
| 2706 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.02 USD | -3.35% | -4.27% | +8.60% | +80.36% | 697.89 M USD | ||
| 2710 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 35.62 USD | -2.94% | -4.45% | +25.95% | +107.70% | 696.35 M USD |
Frequently asked questions about CytomX Therapeutics, Inc.
What is the CytomX Therapeutics, Inc. stock price today?
The current price of CytomX Therapeutics, Inc. (CTMX) is 3.21. Over the past 24 hours, the stock has changed by -6.14%. Follow the CTMX chart for real-time price dynamics.
What is the stock ticker of CytomX Therapeutics, Inc.?
CytomX Therapeutics, Inc. trades under the ticker CTMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CytomX Therapeutics, Inc. stock going up?
CTMX has changed by -2.73% over the last week, +0.94% over the last month, and +58.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of CytomX Therapeutics, Inc.?
CytomX Therapeutics, Inc. currently has a market capitalization of 699.46 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were CytomX Therapeutics, Inc. earnings last quarter?
Last quarter, CytomX Therapeutics, Inc. reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was CytomX Therapeutics, Inc. revenue for the last quarter?
CytomX Therapeutics, Inc. reported quarterly revenue of 1.42 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was CytomX Therapeutics, Inc. net income for the last quarter?
CytomX Therapeutics, Inc. reported net income of -20.67 M for the last quarter. The previous quarter showed -18.25 M, which means net income changed by -13.25%.
How many employees does CytomX Therapeutics, Inc. have?
As of the latest available data, CytomX Therapeutics, Inc. has 69 employees. Workforce size can provide additional context about the company's scale and operations.
What is CytomX Therapeutics, Inc. EBITDA?
CytomX Therapeutics, Inc. EBITDA is -25.14 M, and its EBITDA margin is -1 772.64%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CytomX Therapeutics, Inc. stock?
You can buy CytomX Therapeutics, Inc. (CTMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CytomX Therapeutics, Inc. stock?
Investing in CytomX Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTMX chart and related analysis on metatrader.com as part of your research.